Literature DB >> 2253031

A novel effect of MPTP: the selective suppression of paradoxical sleep in cats.

K Pungor1, M Papp, K Kékesi, G Juhász.   

Abstract

We studied the effect of MPTP on sleep-wakefulness cycle in cats. Five mg/kg n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was administered i.p. for 5 consecutive days. Electrocorticographic, electrooculographic and electromyographic recordings were performed before (5 days), during (5 days) and after (14 days) the treatment. Total selective paradoxical sleep deprivation was observed from the first injection. This effect lasted 6-9 days after the last dose, while the relative amount of slow wave sleep increased. The Berg-Fourier analysis showed no significant change in the EEG power spectra of slow-wave sleep during the paradoxical sleep deprivation compared to control period. Recurrence of paradoxical sleep was parallel to the disappearance of the motor symptoms. Histopathological investigation showed neuronal loss mainly in the substantia nigra. Our present study suggests a complex behavioral effect of MPTP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253031     DOI: 10.1016/0006-8993(90)90880-k

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Circadian distribution of motor-activity in unilaterally 6-hydroxy-dopamine lesioned rats.

Authors:  Paul Christian Baier; Pablo Branisa; Reinhard Koch; Jan Schindehütte; Walter Paulus; Claudia Trenkwalder
Journal:  Exp Brain Res       Date:  2006-01-24       Impact factor: 1.972

2.  Basal ganglia beta oscillations during sleep underlie Parkinsonian insomnia.

Authors:  Aviv D Mizrahi-Kliger; Alexander Kaplan; Zvi Israel; Marc Deffains; Hagai Bergman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-07       Impact factor: 11.205

Review 3.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

4.  REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease.

Authors:  Peternella S Verhave; Marjan J Jongsma; Roland M Van den Berg; José C Vis; Raymond A P Vanwersch; August B Smit; Eus J W Van Someren; Ingrid H C H M Philippens
Journal:  Sleep       Date:  2011-08-01       Impact factor: 5.849

Review 5.  Sleep disturbances in Alzheimer's and Parkinson's diseases.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2012-05-03       Impact factor: 3.843

6.  Paradoxical sleep deprivatory effect of a single low dose of MPTP which did not produce dopaminergic cell loss.

Authors:  K Pungor; A Hajnal; K A Kékesi; G Juhász
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations.

Authors:  Charlotte Laloux; Philippe Derambure; Alexandre Kreisler; Elise Houdayer; Servane Bruezière; Régis Bordet; Alain Destée; Christelle Monaca
Journal:  Exp Brain Res       Date:  2008-01-26       Impact factor: 1.972

8.  Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.

Authors:  Marielle Zoetmulder; Miki Nikolic; Heidi Biernat; Lise Korbo; Lars Friberg; Poul Jennum
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

9.  Neurotoxic N-methyl-D-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep-wake organization.

Authors:  Y Y Lai; T Shalita; T Hajnik; J P Wu; J S Kuo; L G Chia; J M Siegel
Journal:  Neuroscience       Date:  1999-05       Impact factor: 3.590

Review 10.  Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder.

Authors:  Yuan-Yang Lai; Jerome M Siegel
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.